Open an account

Ventas

VTR · NYSE

$86.49+$1.98 (+2.34%)TodayMarket closed ·
Prev close $84.51

About VTR

Ventas, Inc. engages in the acquisition and ownership of seniors housing and healthcare properties. The company is headquartered in Chicago, Illinois and currently employs 542 full-time employees. The firm holds a portfolio that includes senior housing communities, outpatient medical buildings, research centers, hospitals and healthcare facilities located in North America and the United Kingdom. The firm owns approximately 1,400 properties in North America and the United Kingdom. The company operates in three segments: senior housing operating portfolio (SHOP), outpatient medical and research portfolio (OM&R), and triple-net leased properties (NNN). In its SHOP segment, it owns and invests in senior housing communities. The company engages third-party managers to operate the communities on its behalf. In its OM&R segment, it primarily acquires, owns, develops, leases and manages outpatient medical buildings and research centers. In its NNN segment, it invests in and owns senior housing communities, skilled nursing facilities (SNFs), long-term acute care facilities (LTACs), and freestanding inpatient rehabilitation facilities (IRFs).

Employees
542
Headquarters
Chicago, Illinois
Listed
Apr 2, 1992
Sector
Real Estate
Industry
Health Care REITs
Website
ventasreit.com

VTR key statistics

Market cap
45.02B
Price-earnings ratio
159.45
Dividend yield
2.02%
Average volume
3.93M
Volume
2.27M
Open price
$85.16
High today
$86.82
Low today
$85.11
52 Week high
$101.60
52 Week low
$68.15

Ventas (VTR) at a glance

As of Oct 20, 2026, Ventas (VTR) shares are priced at $86.49, giving the company a market cap of 45.02B, a price-to-earnings ratio of 159.45 and a dividend yield of 2.02%.

Today the stock has traded between $85.11 and $86.82. The current price is 1.6% above the day's low and 0.4% below its high.

Volume so far is 2.27M shares, below the average of 3.93M shares a day.

Over the past year Ventas has ranged from $68.15 to $101.60, and now sits 55% of the way up that range.

Ventas met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.15 per share against an estimate of $0.1342.

The average analyst price target is $104.14, 20.4% above the current price, from 16 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

81%of 16 analyst ratings say Buy
  • Buy81.3%
  • Hold18.8%
  • Sell0.0%
Price target · 23 analystsAvg $104.14
Low
$90.90
Now
$86.49
High
$118.65

VTR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 148.7% on average.

  1. Q3 FY24: reported $0.05 per share against an estimate of -$0.0328
  2. Q4 FY24: reported $0.13 per share against an estimate of $0.0177
  3. Q1 FY25: reported $0.10 per share against an estimate of $0.0687
  4. Q2 FY25: reported $0.15 per share against an estimate of $0.1434
  5. Q3 FY25: reported $0.14 per share against an estimate of $0.1212
  6. Q4 FY25: reported $0.15 per share against an estimate of $0.0848
  7. Q1 FY26: reported $0.11 per share against an estimate of $0.1241
  8. Q2 FY26: reported $0.15 per share against an estimate of $0.1342

VTR news

  • Press releaseBusiness Wire

    Ventas Announces Third Quarter 2026 Earnings Release Date and Conference Call

  • Press releaseBusiness Wire

    Ventas Declares Quarterly Dividend of $0.52 Per Common Share

  • Press releaseBusiness Wire

    Ventas Releases 2025-2026 Corporate Sustainability Report

  • Press releaseBusiness Wire

    Ventas Reports 2026 Second Quarter Results

  • Press releaseBusiness Wire

    Ventas Announces Second Quarter 2026 Earnings Release Date and Conference Call

  • Press releaseBusiness Wire

    Ventas Names Andrew L. Wattula EVP Outpatient Medical & Research

  • Press releaseBusiness Wire

    Ventas Chairman and CEO Debra A. Cafaro to Receive Cyrus McCormick Making History Award for Historic Corporate Achievement

  • Press releaseBusiness Wire

    Ventas Issues Business Update and Will Participate in Investor Meetings at Nareit's REITweek 2026 Investor Conference

Similar companies

Companies in the same industry as Ventas

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.